Noile-Immune Biotech Management
Management criteria checks 2/4
Noile-Immune Biotech's CEO is Koji Tamada, appointed in Sep 2020, has a tenure of 4.17 years. directly owns 8.66% of the company’s shares, worth ¥645.00M. The average tenure of the management team and the board of directors is 4.2 years and 5.4 years respectively.
Key information
Koji Tamada
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 4.2yrs |
CEO ownership | 8.7% |
Management average tenure | 4.2yrs |
Board average tenure | 5.4yrs |
CEO
Koji Tamada (56 yo)
4.2yrs
Tenure
Mr. Koji Tamada, M.D., Ph.D. is President and Chief Executive Officer of Noile-Immune Biotech Inc. from September 2020 and also serves as its Representative Director since March 2016.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4.2yrs | no data | 8.66% ¥ 652.5m | |
CFO, GM of Administration & Director | 4.7yrs | no data | no data | |
COO, GM of Business Planning & Research Department and Director | 1.8yrs | no data | 0.058% ¥ 4.3m |
4.2yrs
Average Tenure
48yo
Average Age
Experienced Management: 4893's management team is considered experienced (4.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 8.7yrs | no data | 8.66% ¥ 652.5m | |
CFO, GM of Administration & Director | 4.4yrs | no data | no data | |
COO, GM of Business Planning & Research Department and Director | 5.5yrs | no data | 0.058% ¥ 4.3m | |
Independent Outside Director | less than a year | no data | no data | |
Independent Outside Director | 4.7yrs | no data | no data | |
Outside Audit & Supervisory Board Member | 9.3yrs | no data | 0.81% ¥ 60.9m | |
Full-Time Outside Audit & Supervisory Board Member | 5.3yrs | no data | no data | |
Outside Audit & Supervisory Board Member | 5.5yrs | no data | no data |
5.4yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 4893's board of directors are considered experienced (5.4 years average tenure).